Life Science & Medical Technology

Bio/Medtech
1st Japan-Germany-Switzerland Workshop for Enzyme Technology and Bioprocess Development
On September 10th – 12th the first Japan-Germany-Switzerland Workshop for the Enzyme Technology took place in Toyama, Japan. Building on the history of exchange on these topics between Japan and Switzerland in the field of bioprocess development for 30 years and that between Germany in the area of enzyme technology for 40 years, the newly evolved integrated workshop attracted approximately 70 participants from academia and industry for in-depth discussions.
Swiss co-organized JCA-Mauvernay Award in its 15th year
The 2019 JCA-Mauvernay Award, co-organized by the Japanese Cancer Association (JCA) and Swiss global biopharmaceutical company Debiopharm Group, was awarded to Doctors Ryohei Katayama from the Japanese Foundation for Cancer Research and Shinichi Yachida from Osaka University. This year marked the 15th anniversary of the recognition of outstanding research in the field of oncology in Japan.
Ig Nobel Prizes encourage people to enjoy science with a smile
Winners of the Ig Nobel Prize — an award that praises humorous achievements in scientific research — have been announced. Although the prize parodies the renowned Nobel Prize, there is much to be learned from it, such as a positive attitude toward enjoying science.
Fujifilm South Africa expands health care products and solutions in Africa
Celebrating 85 years this year, Fujifilm Holdings Corp. is recognized as one of the world’s leading photographic and innovation-driven technology companies. The company’s main business segments cover imaging solutions, health care, industrial products and document solutions. In recent years the company has increased its ability to deliver solutions to the health care and technology sectors. Fujifilm South Africa’s Fujifilm Innovation Center Africa in Roodepoort, Johannesburg, has opened its doors to new opportunities, products and services.
Japanese drugmaker Santen forays into India
Japan's Santen Pharmaceutical will enter the Indian market this year with glaucoma and dry-eye medicines, tapping demand in a country where economic growth has helped improve medical infrastructure.